Structural (dys)connectivity associates with cholinergic cell density of the nucleus basalis of Meynert in Alzheimer’s disease

Chen‐Pei Lin, Irene Frigerio, Baayla D.c. Boon, Zihan Zhou, Annemieke J.m. Rozemüller, Femke H. Bouwman, Menno M. Schoonheim, Wilma D. J. van de Berg, Laura E. JonkmanbioRxiv 2021 · DOI

TL;DR

This study combines post-mortem MRI and histopathology to investigate the nucleus basalis of Meynert (NbM) in Alzheimer's disease (AD). They found that AD patients show reduced NbM volume and altered microstructural integrity, with decreased cholinergic cell density linked to damage in temporal lobe connections, particularly in those with amnestic AD. This highlights the NbM's significant role in memory deficits in AD.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by cognitive decline, particularly memory loss in the amnestic subtype. This decline is strongly linked to the degeneration of cholinergic neurons in the basal forebrain, specifically the nucleus basalis of Meynert (NbM). While AD is known to involve amyloid-beta (Aβ) plaques and tau tangles, and NbM atrophy is observed, the precise relationship between NbM pathology, its structural connections to the cortex, and the resulting cognitive deficits, especially in different AD subtypes, remains unclear. This paper aims to bridge this gap by directly linking post-mortem MRI measures of NbM structure and connectivity with detailed histopathological findings of cholinergic cell density and AD pathology.

Methods

The researchers employed a combined post-mortem approach using 3T T1-weighted MRI and diffusion-weighted imaging (DWI) on 19 AD donors and 9 non-neurological controls.

  • MRI Acquisition and Analysis: Whole brains were scanned in situ (still in the cranium) to obtain high-resolution T1-weighted images for anatomical delineation and volume assessment of the NbM. DWI was used to assess the microstructural integrity of the NbM and its white matter tracts. Standard image processing techniques were applied, including lesion filling, brain extraction, normalization, and registration to MNI space. NbM was manually delineated based on anatomical landmarks. Probabilistic tractography was used to reconstruct tracts from the NbM to various cortical regions.
  • Histopathology: Following MRI, brains were autopsied, and tissue blocks containing the NbM were processed. Immunohistochemistry was performed to quantify choline acetyltransferase (ChAT) for cholinergic cell density, as well as amyloid-beta (Aβ) and phosphorylated-tau (p-tau) for AD pathology.
  • Statistical Analysis: General linear models (GLMs) were used to compare MRI and histopathological measures between AD patients and controls, and between amnestic and non-amnestic AD subtypes. Partial correlations and linear mixed models were used to examine associations between these measures. Covariates like age, gender, and post-mortem delay were included. Multiple comparisons were corrected using Bonferroni correction and False Discovery Rate (FDR).

Datasets

The study utilized a dataset of 28 post-mortem brain donors:

  • 19 donors diagnosed with Alzheimer's disease (10 amnestic, 9 non-amnestic).
  • 9 non-neurological control donors.

These donors were recruited through the Alzheimer Center Amsterdam and the Netherlands Brain Bank (NBB).

Key Insights and Ideas

  • NbM is a key player in amnestic AD: The study strongly implicates the NbM and its connections as central to the memory deficits seen in amnestic AD.
  • MRI and Histopathology are complementary: Combining in-situ MRI with detailed histology provides a powerful way to link structural brain changes with underlying cellular pathology.
  • Cholinergic degeneration is widespread: The damage isn't confined to the NbM itself but extends to its projections, particularly to the temporal lobe.
  • Subtype specificity matters: The observed associations between cholinergic cell density and tract integrity are more pronounced in amnestic AD, suggesting a specific vulnerability of this pathway in memory-related AD.

Key Results

  • NbM Volume and Integrity: Alzheimer's disease donors showed significantly lower normalized NbM volumes in both hemispheres compared to controls. While NbM FA and MD showed some group differences, the overall microstructural integrity of the NbM was altered in AD.
  • Cholinergic Cell Density and Tract Integrity: Decreased cholinergic cell density in the NbM was associated with reduced microstructural integrity (higher MD) of white matter tracts connecting the NbM to the temporal lobe, specifically the temporal pole of the superior temporal gyrus and the parahippocampal gyrus.
  • Subtype Specificity: The association between cholinergic cell density and altered temporal lobe tract integrity was specific to the amnestic AD subtype. Non-amnestic AD donors did not show this specific association.
  • Pathology Loads: AD donors had significantly higher Aβ and p-tau loads compared to controls, but ChAT cell density did not differ significantly between groups, highlighting the variability within the AD cohort.

Limitations and Future Work

  • Sample Size: The authors acknowledge that their sample size is small, particularly for subtype analyses. They emphasize the need for further validation in larger cohorts with diverse phenotypes.
  • Tissue Block Collection: NbM tissue blocks were collected retrospectively from brain banks, not directly at autopsy. This could introduce variability in the dissecting plane and thus in the NbM subsectors analyzed. Future research could aim for more consistent dissection.
  • Co-morbid Pathology: The study did not extensively investigate co-morbid pathologies like TDP-43 or Lewy body pathology, which can influence AD presentation. Future research is encouraged to account for these factors.
  • Subsector Heterogeneity: The study noted heterogeneity in cholinergic cell loss within different NbM subsectors. While they attempted to account for this, further investigation into these subsectors could provide more nuanced insights.

The authors suggest that future research should focus on larger cohorts, explore different AD phenotypes, and investigate the impact of co-morbid pathologies to better understand the mechanisms underlying cholinergic degeneration in AD.

Summary updated

Abstract

Abstract Cognitive deficits in Alzheimer’s disease, specifically amnestic (memory dominant) deficits, are associated with cholinergic degeneration in the basal forebrain. The cholinergic nucleus within the basal forebrain, the nucleus basalis of Meynert, exhibits local atrophy and reduced cortical tract integrity on MRI, and reveals amyloid-β and phosphorylated-tau pathology at autopsy. To better understand the pathophysiology of nucleus basalis of Meynert atrophy and its neocortical projections in Alzheimer’s disease, we utilized a combined post-mortem in-situ MRI and histopathology approach. A total of 19 Alzheimer’s disease (10 amnestic and 9 non-amnestic) and 9 non-neurological control donors underwent 3T T1-weighted MRI for anatomical delineation and volume assessment of the nucleus basalis of Meynert, and diffusion-weighted imaging for microstructural assessment of the nucleus and its projections. At subsequent brain autopsy, tissue dissection and immunohistochemistry were performed for amyloid-β, phosphorylated-tau and choline acetyltransferase. Compared to controls, we observed an MRI-derived volume reduction and altered microstructural integrity of the nucleus basalis of Meynert in Alzheimer’s disease donors. Furthermore, decreased cholinergic cell density was associated with reduced integrity of the nucleus and its tracts to the temporal lobe, specifically to the temporal pole of the superior temporal gyrus, and the parahippocampal gyrus. The association between cholinergic cell density and alteration to cortical tracts was specific for amnestic, compared to non-amnestic Alzheimer’s disease donors. Our study illustrates that the nucleus basalis of Meynert is severely affected in amnestic Alzheimer’s disease, both in terms of pathology within the nucleus, but also in terms of damage to its cortical projections, specifically to the temporal lobe, which may contribute to the observed cognitive deterioration.
BibTeX
@misc{lin2021structural,
  author = {Chen‐Pei Lin and Irene Frigerio and Baayla D.C. Boon and Zihan Zhou and Annemieke J.M. Rozemüller and Femke H. Bouwman and Menno M. Schoonheim and Wilma D. J. van de Berg and Laura E. Jonkman},
  title = {{Structural (dys)connectivity associates with cholinergic cell density of the nucleus basalis of Meynert in Alzheimer’s disease}},
  year = {2021},
  doi = {10.1101/2021.08.02.454716},
  howpublished = {bioRxiv},
}
Figure